Balsalazide Disodium Capsule
Product Images NDC 72789-149

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Balsalazide Disodium (NDC 72789-149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789149 Label (72789149)

Each capsule contains 750 mg Balsalazide Disodium. This medicine is marketed and packaged by USP. The usual dosage is mentioned in the package insert. It should be stored at room temperature between 20°C to 25°C. These capsules should be dispensed in a tight, child-resistant container as defined in USP/NF to keep them out of the reach of children. The lot number for this medicine is J19c06, and it expires in October 2021. The manufacturer of this medicine is West-Ward Pharmaceuticals. This text describes the packaging and usage instructions for the medicine.*

FDA Label Image

Chem.jpg (Chem)

FDA Label Image

Figure1.jpg (Figure1)

This text is a mix of numerical figures and medical terms. It appears to show percentages of patient improvements with respect to various medical conditions such as Stool Blood, Stool Frequency, and Sigmoidoscopy. There are also references to two types of Balsalazide Disodium, one with 2.25 g and the other with 6.75 g, along with their respective mesalamine equivalents. Overall, it is not clear what this information is trying to convey or in what context it is presented.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.